Efsubaglutide alfa in adults with overweight or obesity: Protocol for a seamless, adaptive phase 2b/3 randomized, double‐blind, placebo‐controlled trial ( LIGHT 2)

Documenti analoghi

• Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight ( LIGHT 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial
  di: Fei Gao, et al.
  Pubblicazione: (2026)
• Efficacy and safety of intragastric expandable oral capsules in adults with overweight or obesity: A randomized, double‐blind, placebo‐controlled trial
  di: Difei Lu, et al.
  Pubblicazione: (2024)
• Efficacy and safety of diacerein monotherapy in adults with obesity: A randomized, double‐blind, placebo‐controlled trial
  di: Yingying Xiang, et al.
  Pubblicazione: (2024)
• Efficacy and safety of Efsubaglutide Alfa in “overrun” patients in the SUPER2 trial: A post‐hoc analysis for comprehensive evaluation
  di: Weiping Jia, et al.
  Pubblicazione: (2025)
• Association between patient‐reported eating behaviours and weight change: Secondary analyses of a randomized, double‐blind trial comparing retatrutide and placebo in people with obesity or overweight
  di: Chisom Kanu, et al.
  Pubblicazione: (2025)